Two years in, here's how sports betting is impacting North Carolina.

Generate Capital (“Generate”), a leading infrastructure investment platform, today announced the sale of Equinox Growers, a Virginia-based developer and operator of high-tech greenhouses to Taylor ...

Why do individual web pages now require as much memory to run as an entire operating system did 30 years ago? Ad tech, baby.

New AI-assisted development approach reduces costs and accelerates delivery timelines for modern JavaScript applications ...

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company's success ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...